Filing metadata

Accession number
0001209191-18-025216
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Apr 17, 2018
Reporting period
Apr 13, 2018
Description
Insider transaction

Explore SEC Filings Hub